KR910019623A - 상승병용을 이용한 안고혈압 치료 - Google Patents

상승병용을 이용한 안고혈압 치료 Download PDF

Info

Publication number
KR910019623A
KR910019623A KR1019910008275A KR910008275A KR910019623A KR 910019623 A KR910019623 A KR 910019623A KR 1019910008275 A KR1019910008275 A KR 1019910008275A KR 910008275 A KR910008275 A KR 910008275A KR 910019623 A KR910019623 A KR 910019623A
Authority
KR
South Korea
Prior art keywords
pharmaceutically acceptable
composition
dihydro
component
acceptable salt
Prior art date
Application number
KR1019910008275A
Other languages
English (en)
Other versions
KR960010437B1 (ko
Inventor
류지 우에노
Original Assignee
우에노 류조
가부시끼가이샤 우에노세이야꾸오오요겡뀨소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15092428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR910019623(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 우에노 류조, 가부시끼가이샤 우에노세이야꾸오오요겡뀨소 filed Critical 우에노 류조
Publication of KR910019623A publication Critical patent/KR910019623A/ko
Application granted granted Critical
Publication of KR960010437B1 publication Critical patent/KR960010437B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

내용 없음

Description

상승병용을 이용한 안고혈압 치료
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 약학적으로 허용가능한 담체, 희석제 또는 부형제와 함께 안압강하에 상승적인 (a) 13,14-디히드로-15-케토프로스타글란딘 화합물 및 (b) 콜린작동제의 병용을 포함하는 고혈압 치료용 약학적 조성물.
  2. 제1항에 있어서, 성분(a)가13,14-디히드로-15-케토-프로스타글란딘 A,B,C,D,E 또는 F,또는 약학적으로 허용가능한 그의 염, 또는 약학적으로 허용가능한 그의 에스테르인 조성물.
  3. 제1항에 있어서, 성분(a)가13,14-디히드로-15-케토-20-에틸-프로스타글란딘 또는 그의 약학적으로 허용가능한 그의 염, 또는 약학적으로 허용가능한 그의 에스테르인 조성물.
  4. 제1항에 있어서, 성분(a)가13,14-디히드로-15-케토-20-에틸-프로스타글란딘 또는 약학적으로 허용가능한 그의 염, 또는 그의 저급 알킬에스테르인 조성물.
  5. 제1항에 있어서, 성분(a)가13,14-디히드로-15-케토-20-저급알킬프로스타글란딘 F2a또는 약학적으로 허용가능한 그의 염, 또는 그의 저급알킬에스테르인 조성물.
  6. 제1항에 있어서,성분(a)13,14-디히드로-15-케토-20-에틸-프로스타글란딘F2a 또는 약학적으로 허용가능한 그의 염, 또는 그의 저급 알킬에스테르인 조성물.
  7. 제1항에 있어서, 성분(b)가 필로카프핀, 아세틸콜린, 메타콜린, 카르바콜 또는, 적당하다면, 약학적으로 허용가능한 그의 염인 조성물.
  8. 제1항에 있어서, 성분(a)및(b)가1:10내지 1:200의 (a):(b)의 비율로 투여되는 조성물.
  9. 제1항에 있어서, 성분(a)및(b)가 동시에 또는 연속적으로 투여되는 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910008275A 1990-05-22 1991-05-22 상승병용을 이용한 안고혈압 치료 KR960010437B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP132912 1990-05-22
JP13291290 1990-05-22

Publications (2)

Publication Number Publication Date
KR910019623A true KR910019623A (ko) 1991-12-19
KR960010437B1 KR960010437B1 (ko) 1996-08-01

Family

ID=15092428

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910008275A KR960010437B1 (ko) 1990-05-22 1991-05-22 상승병용을 이용한 안고혈압 치료

Country Status (9)

Country Link
US (1) US5397797A (ko)
EP (1) EP0458589B1 (ko)
JP (1) JP2511587B2 (ko)
KR (1) KR960010437B1 (ko)
AT (1) ATE117208T1 (ko)
CA (1) CA2042934C (ko)
DE (1) DE69106777T2 (ko)
DK (1) DK0458589T3 (ko)
ES (1) ES2069823T3 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641794A (en) * 1991-03-28 1997-06-24 Eli Lilly Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
CA2146127C (en) * 1992-10-13 2000-06-13 Louis Desantis, Jr. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
AU1138097A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure
EP0949688A1 (de) * 1998-03-31 1999-10-13 Phototronics Solartechnik GmbH Dünnschichtsolarzelle, Verfahren zu deren Herstellung sowie Vorrichtung zur Durchführung des Verfahrens
CA2433346A1 (en) * 2000-12-29 2002-07-11 John J. Egan Method for treating glaucoma ib
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
US20040007269A1 (en) * 2002-07-12 2004-01-15 Larsen Todd W. Inline pressure reducing regulator
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US7757710B2 (en) * 2006-06-19 2010-07-20 Tescom Corporation High-pressure regulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0242580B1 (en) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Use of a, b and c prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
EP0580268B1 (en) * 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Ocular hypotensive agents

Also Published As

Publication number Publication date
DE69106777D1 (de) 1995-03-02
ATE117208T1 (de) 1995-02-15
DE69106777T2 (de) 1995-05-18
CA2042934A1 (en) 1991-11-23
EP0458589A1 (en) 1991-11-27
DK0458589T3 (da) 1995-04-03
CA2042934C (en) 2002-04-23
JPH04253912A (ja) 1992-09-09
KR960010437B1 (ko) 1996-08-01
ES2069823T3 (es) 1995-05-16
JP2511587B2 (ja) 1996-06-26
US5397797A (en) 1995-03-14
EP0458589B1 (en) 1995-01-18

Similar Documents

Publication Publication Date Title
KR870005637A (ko) 약물 데포
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
KR930001913A (ko) 안염 치료방법
KR910000169A (ko) 포유류에서 이식 거부를 억제시키는 라파마이신의 용도
KR950016745A (ko) 생리증상의 치료방법 및 이를 위한 조성물
KR950016744A (ko) 트롬빈을 저해하는 방법
KR910019623A (ko) 상승병용을 이용한 안고혈압 치료
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
DE68911891T2 (de) Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung.
ATE181236T1 (de) Steigerung des glutathionspiegels durch glutamin
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
BR0012442A (pt) Medicamento com ação protetora contra substâncias oxidantes tóxicas e particularmente contra substâncias cardiotóxicas
CA2042972A1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
KR910019621A (ko) 상승병용을 이용한 안고혈압 치료
KR910019622A (ko) 안과용 상승적 병용으로 안고혈압의 치료
KR910000130A (ko) 진경제
KR920017654A (ko) 상승작용성 배합물에 의한 안내압 항진증의 치료방법
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물
KR930019214A (ko) 안과용 아르가트로반 제제
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
KR960700711A (ko) 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases)
KR890003372A (ko) 피리미도[2,1-b] 벤조티아졸 유도체로된 동맥경화 치료의약
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
KR920700641A (ko) 클로르메티아졸의 신경 변성 예방 및(또는) 치료용 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030702

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee